Logo image of CABKA.AS

CABKA (CABKA.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:CABKA - NL00150000S7 - Common Stock

1.8 EUR
-0.06 (-3.23%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

2

Overall CABKA gets a fundamental rating of 2 out of 10. We evaluated CABKA against 14 industry peers in the Containers & Packaging industry. Both the profitability and financial health of CABKA have multiple concerns. CABKA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CABKA had negative earnings in the past year.
In the past year CABKA had a positive cash flow from operations.
CABKA had negative earnings in 4 of the past 5 years.
In the past 5 years CABKA always reported a positive cash flow from operatings.
CABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFCABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

CABKA has a Return On Assets of -7.60%. This is amonst the worse of the industry: CABKA underperforms 85.71% of its industry peers.
CABKA has a Return On Equity of -23.29%. This is amonst the worse of the industry: CABKA underperforms 85.71% of its industry peers.
Industry RankSector Rank
ROA -7.6%
ROE -23.29%
ROIC N/A
ROA(3y)-7.32%
ROA(5y)-4.89%
ROE(3y)-19.85%
ROE(5y)-13.7%
ROIC(3y)N/A
ROIC(5y)N/A
CABKA.AS Yearly ROA, ROE, ROICCABKA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

CABKA's Operating Margin has declined in the last couple of years.
CABKA's Gross Margin of 45.45% is fine compared to the rest of the industry. CABKA outperforms 64.29% of its industry peers.
In the last couple of years the Gross Margin of CABKA has remained more or less at the same level.
CABKA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.45%
OM growth 3Y-68.98%
OM growth 5Y-54.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-0.57%
CABKA.AS Yearly Profit, Operating, Gross MarginsCABKA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

2

2. Health

2.1 Basic Checks

CABKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CABKA has about the same amount of shares outstanding.
The number of shares outstanding for CABKA has been increased compared to 5 years ago.
The debt/assets ratio for CABKA is higher compared to a year ago.
CABKA.AS Yearly Shares OutstandingCABKA.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CABKA.AS Yearly Total Debt VS Total AssetsCABKA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.07, we must say that CABKA is in the distress zone and has some risk of bankruptcy.
CABKA has a Altman-Z score of 1.07. This is in the lower half of the industry: CABKA underperforms 71.43% of its industry peers.
CABKA has a debt to FCF ratio of 12.12. This is a negative value and a sign of low solvency as CABKA would need 12.12 years to pay back of all of its debts.
CABKA has a Debt to FCF ratio (12.12) which is in line with its industry peers.
A Debt/Equity ratio of 0.19 indicates that CABKA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.19, CABKA is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 12.12
Altman-Z 1.07
ROIC/WACCN/A
WACC6.27%
CABKA.AS Yearly LT Debt VS Equity VS FCFCABKA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

CABKA has a Current Ratio of 0.68. This is a bad value and indicates that CABKA is not financially healthy enough and could expect problems in meeting its short term obligations.
CABKA has a Current ratio of 0.68. This is amonst the worse of the industry: CABKA underperforms 85.71% of its industry peers.
CABKA has a Quick Ratio of 0.68. This is a bad value and indicates that CABKA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.37, CABKA is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.37
CABKA.AS Yearly Current Assets VS Current LiabilitesCABKA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

CABKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -170.16%.
CABKA shows a decrease in Revenue. In the last year, the revenue decreased by -2.88%.
CABKA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.52% yearly.
EPS 1Y (TTM)-170.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.07%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y2.28%
Revenue growth 5Y2.52%
Sales Q2Q%-2.49%

3.2 Future

CABKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.05% yearly.
Based on estimates for the next years, CABKA will show a small growth in Revenue. The Revenue will grow by 5.15% on average per year.
EPS Next Y-306.34%
EPS Next 2Y-20.85%
EPS Next 3Y43.46%
EPS Next 5Y45.05%
Revenue Next Year-1.33%
Revenue Next 2Y2.34%
Revenue Next 3Y4.05%
Revenue Next 5Y5.15%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CABKA.AS Yearly Revenue VS EstimatesCABKA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
CABKA.AS Yearly EPS VS EstimatesCABKA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 -0.1 0.2 -0.2 0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CABKA. In the last year negative earnings were reported.
Also next year CABKA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CABKA.AS Price Earnings VS Forward Price EarningsCABKA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

CABKA's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CABKA is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.8
EV/EBITDA 8.59
CABKA.AS Per share dataCABKA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as CABKA's earnings are expected to grow with 43.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.85%
EPS Next 3Y43.46%

More info and screens

0

5. Dividend

5.1 Amount

CABKA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CABKA

AMS:CABKA (12/12/2025, 7:00:00 PM)

1.8

-0.06 (-3.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners53.63%
Ins Owner ChangeN/A
Market Cap73.26M
Revenue(TTM)179.57M
Net Income(TTM)-12.15M
Analysts85.45
Price Target3.2 (77.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP-30.5%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.09%
PT rev (3m)-9.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-39.13%
EPS NY rev (3m)-146.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.2%
Revenue NY rev (3m)-3.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.41
P/FCF 11.8
P/OCF 3.48
P/B 1.4
P/tB 1.47
EV/EBITDA 8.59
EPS(TTM)-0.49
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.15
FCFY8.47%
OCF(TTM)0.52
OCFY28.72%
SpS4.41
BVpS1.28
TBVpS1.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.6%
ROE -23.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.45%
FCFM 3.46%
ROA(3y)-7.32%
ROA(5y)-4.89%
ROE(3y)-19.85%
ROE(5y)-13.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-68.98%
OM growth 5Y-54.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-0.57%
F-Score4
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 12.12
Debt/EBITDA 0.57
Cap/Depr 73.55%
Cap/Sales 8.26%
Interest Coverage N/A
Cash Conversion 122.24%
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.37
Altman-Z 1.07
F-Score4
WACC6.27%
ROIC/WACCN/A
Cap/Depr(3y)138.03%
Cap/Depr(5y)116.14%
Cap/Sales(3y)12.71%
Cap/Sales(5y)11.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-170.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.07%
EPS Next Y-306.34%
EPS Next 2Y-20.85%
EPS Next 3Y43.46%
EPS Next 5Y45.05%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y2.28%
Revenue growth 5Y2.52%
Sales Q2Q%-2.49%
Revenue Next Year-1.33%
Revenue Next 2Y2.34%
Revenue Next 3Y4.05%
Revenue Next 5Y5.15%
EBIT growth 1Y-966.57%
EBIT growth 3Y-68.28%
EBIT growth 5Y-53%
EBIT Next Year638.48%
EBIT Next 3Y116.29%
EBIT Next 5Y66.92%
FCF growth 1Y303.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.9%
OCF growth 3Y-9.12%
OCF growth 5Y-4.78%

CABKA / CABKA.AS FAQ

What is the ChartMill fundamental rating of CABKA (CABKA.AS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CABKA.AS.


What is the valuation status for CABKA stock?

ChartMill assigns a valuation rating of 2 / 10 to CABKA (CABKA.AS). This can be considered as Overvalued.


Can you provide the profitability details for CABKA?

CABKA (CABKA.AS) has a profitability rating of 2 / 10.


What is the expected EPS growth for CABKA (CABKA.AS) stock?

The Earnings per Share (EPS) of CABKA (CABKA.AS) is expected to decline by -306.34% in the next year.


How sustainable is the dividend of CABKA (CABKA.AS) stock?

The dividend rating of CABKA (CABKA.AS) is 0 / 10 and the dividend payout ratio is -30.5%.